Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, d'Arminio Monforte A, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group. Byonanebye DM, et al. Lancet HIV. 2024 May;11(5):e321-e332. doi: 10.1016/S2352-3018(23)00328-4. Epub 2024 Apr 12. Lancet HIV. 2024. PMID: 38621392
Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: a systematic review and meta-analysis.
Mulindwa F, Kamal H, Castelnuovo B, Byonanebye DM, Schwarz JM, Bollinger R, Brusselaers N. Mulindwa F, et al. Among authors: byonanebye dm. BMJ Open Diabetes Res Care. 2023 Feb;11(1):e003136. doi: 10.1136/bmjdrc-2022-003136. BMJ Open Diabetes Res Care. 2023. PMID: 36754450 Free PMC article.
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
Byonanebye DM, Polizzotto MN, Neesgaard B, Sarcletti M, Matulionyte R, Braun DL, Castagna A, de Wit S, Wit F, Fontas E, Vehreschild JJ, Vesterbacka J, Greenberg L, Hatleberg C, Garges H, Gallant J, Volny Anne A, Öllinger A, Mozer-Lisewska I, Surial B, Spagnuolo V, Necsoi C, van der Valk M, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group. Byonanebye DM, et al. HIV Med. 2022 Sep;23(8):895-910. doi: 10.1111/hiv.13273. Epub 2022 Mar 1. HIV Med. 2022. PMID: 35233903 Free PMC article.
Willingness to pay for an mHealth anti-retroviral therapy adherence and information tool: Transitioning to sustainability, Call for life randomised study experience in Uganda.
Naggirinya AB, Kyomugisha EL, Nabaggala MS, Nasasira B, Akirana J, Oseku E, Kiragga A, Castelnuovo B, King RL, Katabira E, Byonanebye DM, Lamorde M, Parkes-Ratanshi R. Naggirinya AB, et al. Among authors: byonanebye dm. BMC Med Inform Decis Mak. 2022 Feb 26;22(1):52. doi: 10.1186/s12911-022-01782-0. BMC Med Inform Decis Mak. 2022. PMID: 35219309 Free PMC article. Clinical Trial.
One dollar incentive improves tuberculosis treatment outcomes in programmatic settings in rural Uganda.
Baluku JB, Nakazibwe B, Twinomugisha B, Najjuuko R, Isabella N, Nassozi S, Namiiro S, Katagira W, Byonanebye DM, Sekaggya-Wiltshire C, Muchiri J, Ndungu E, Anguzu G, Mayanja-Kizza H, Andia-Biraro I. Baluku JB, et al. Among authors: byonanebye dm. Sci Rep. 2021 Sep 29;11(1):19346. doi: 10.1038/s41598-021-98770-7. Sci Rep. 2021. PMID: 34588552 Free PMC article. Clinical Trial.
16 results